Skip to content

MORE DATa study

MOnocyte REsponse after acute DAmage of Tissue - a proof of concept study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24413
Enrollment
12
Registered
2018-07-18
Start date
2018-08-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total hip arthroplasty, knee arthroscopy, immune response, monocyte populations

Interventions

5mL of peripheral blood will be drawn preoperatively and postoperatively, with a small margin, at 2 hr, 6 hr, 24 hr, 36 hr, 48 hr and 1 week. After blood samples have been obtained from the patients,
C to the LUMC laboratory site for analysis.

Sponsors

Martini Hospital Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - elective knee arthroscopy or an elective total hip arthroplasty (posterolateral approach) for primary osteoarthritis - between 18 and 70 years of age - signed informed consent

Exclusion criteria

Exclusion criteria: - pre-existing immune deficiency - use of immunosuppressant drugs - orthopaedic surgery in the last two years - cognitive impairments - Evident infectious complications such as pneumonia, surgical site infection (SSI) and/or urinary tract infection (UTI), during postoperative course

Design outcomes

Primary

MeasureTime frame
Expression of early and late markers that identify the maturation stage of monocyte subpopulations.

Secondary

MeasureTime frame
- Absolute numbers of monocyte subpopulations and lymphocyte populations. - Serum interleukines and classical tissue damage marker (CRP and CK) levels.

Contacts

Public ContactA.J. Vries, de

University Medical Center Groningen (UMCG), Department of Anesthesiology, P.O. Box 30001

a.j.de.vries@anest.umcg.nl+31 (0)50 3616161

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)